Immunology
Opinion
Myth of the Month: Vitamin C vs the Common Cold
While vitamin C is safe, there is no evidence for its ability to prevent the common cold.
News
Ocular Microbiome May Be Dry Eye Culprit
Study authors propose that the metabolites of Acinetobacter species, which are more common in dry eyes, contribute to the condition.
News
Severe Flu Confers Higher Risk for Neurologic Disorders Versus COVID
Participants hospitalized with COVID-19 versus influenza were significantly less likely to require care in the following year for migraine,...
News
Sublingual Immunotherapy Safe, Effective for Older Kids
“So now we have the best of both worlds. We harness the safety of SLIT for the first 1-2 years, with the effectiveness of OIT for the remainder of...
News
‘Deep Phenotyping’ Identifies Abnormalities in ME/CFS
Underlying pathophysiology shows autonomic, immune, and metabolic dysfunction.
News
Musculoskeletal Symptoms Often Misattributed to Prior Tick Bites
A new study finds that Ehrlichia or Rickettsia seropositivity was not linked with chronic musculoskeletal symptoms, but alpha-...
News
New tests may finally diagnose long COVID
“I was gobsmacked by the results. We’re seeing a massive dysregulation in those four biomarkers. It’s a combination that we showed was predictive...
News
COVID vaccination protects B cell–deficient patients through T-cell responses
The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write.
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.